Winnergy Medical PCL
SET:WINMED
Cash Flow Statement
Cash Flow Statement
Winnergy Medical PCL
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||
| Net Income |
54
|
54
|
52
|
53
|
50
|
60
|
65
|
68
|
79
|
65
|
61
|
54
|
43
|
38
|
31
|
28
|
25
|
28
|
29
|
32
|
31
|
|
| Depreciation & Amortization |
30
|
21
|
23
|
25
|
28
|
31
|
34
|
36
|
38
|
40
|
41
|
42
|
43
|
45
|
45
|
46
|
47
|
47
|
50
|
51
|
52
|
|
| Other Non-Cash Items |
36
|
33
|
27
|
25
|
23
|
1
|
17
|
15
|
1
|
14
|
1
|
3
|
17
|
14
|
10
|
10
|
2
|
0
|
0
|
3
|
12
|
|
| Cash Taxes Paid |
20
|
20
|
20
|
19
|
22
|
11
|
11
|
12
|
10
|
5
|
5
|
5
|
7
|
7
|
7
|
7
|
5
|
5
|
6
|
6
|
5
|
|
| Cash Interest Paid |
12
|
6
|
5
|
6
|
7
|
4
|
3
|
2
|
2
|
5
|
6
|
8
|
8
|
8
|
9
|
10
|
11
|
13
|
11
|
12
|
13
|
|
| Change in Working Capital |
(4)
|
(53)
|
(94)
|
(98)
|
(51)
|
(33)
|
(25)
|
(226)
|
(209)
|
(165)
|
(177)
|
26
|
(7)
|
(41)
|
(48)
|
(91)
|
(44)
|
27
|
31
|
(8)
|
(86)
|
|
| Cash from Operating Activities |
115
N/A
|
55
-53%
|
8
-85%
|
4
-54%
|
49
+1 215%
|
59
+20%
|
91
+54%
|
(107)
N/A
|
(91)
+15%
|
(46)
+50%
|
(74)
-63%
|
125
N/A
|
96
-23%
|
56
-42%
|
37
-33%
|
(7)
N/A
|
30
N/A
|
103
+244%
|
111
+7%
|
77
-30%
|
10
-87%
|
|
| Investing Cash Flow | ||||||||||||||||||||||
| Capital Expenditures |
(37)
|
(41)
|
(52)
|
(75)
|
(102)
|
(106)
|
(134)
|
(139)
|
(111)
|
(94)
|
(66)
|
(64)
|
(64)
|
(74)
|
(93)
|
(76)
|
(74)
|
(71)
|
(195)
|
(197)
|
(186)
|
|
| Other Items |
(45)
|
(45)
|
(45)
|
(45)
|
3
|
10
|
(2)
|
(2)
|
11
|
4
|
16
|
16
|
0
|
3
|
3
|
4
|
0
|
13
|
13
|
0
|
15
|
|
| Cash from Investing Activities |
(82)
N/A
|
(86)
-5%
|
(97)
-13%
|
(120)
-24%
|
(100)
+17%
|
(96)
+4%
|
(136)
-42%
|
(141)
-3%
|
(100)
+29%
|
(90)
+10%
|
(50)
+45%
|
(48)
+4%
|
(64)
-34%
|
(71)
-10%
|
(90)
-27%
|
(73)
+18%
|
(71)
+3%
|
(59)
+17%
|
(182)
-209%
|
(184)
-1%
|
(171)
+7%
|
|
| Financing Cash Flow | ||||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
85
|
85
|
0
|
445
|
360
|
360
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
31
|
16
|
56
|
76
|
(211)
|
(156)
|
(152)
|
(52)
|
121
|
84
|
102
|
(13)
|
(4)
|
43
|
47
|
74
|
37
|
(55)
|
82
|
125
|
176
|
|
| Cash Paid for Dividends |
0
|
0
|
0
|
0
|
(42)
|
(42)
|
(42)
|
0
|
(26)
|
(26)
|
(26)
|
0
|
(23)
|
(23)
|
(23)
|
0
|
(12)
|
(12)
|
(12)
|
0
|
(10)
|
|
| Other |
(65)
|
(59)
|
(50)
|
(51)
|
(7)
|
(4)
|
(3)
|
(2)
|
(2)
|
(5)
|
(6)
|
(8)
|
(8)
|
(8)
|
(9)
|
(10)
|
(11)
|
(13)
|
(11)
|
(12)
|
(13)
|
|
| Cash from Financing Activities |
(35)
N/A
|
42
N/A
|
90
+116%
|
110
+22%
|
185
+68%
|
158
-15%
|
164
+4%
|
264
+61%
|
93
-65%
|
53
-43%
|
69
+32%
|
(48)
N/A
|
(35)
+27%
|
13
N/A
|
15
+19%
|
42
+171%
|
15
-65%
|
(78)
N/A
|
59
N/A
|
102
+73%
|
153
+50%
|
|
| Change in Cash | ||||||||||||||||||||||
| Net Change in Cash |
(2)
N/A
|
10
N/A
|
1
-91%
|
(6)
N/A
|
135
N/A
|
121
-10%
|
118
-3%
|
16
-86%
|
(99)
N/A
|
(83)
+16%
|
(55)
+34%
|
29
N/A
|
(3)
N/A
|
(2)
+18%
|
(37)
-1 689%
|
(39)
-5%
|
(26)
+32%
|
(33)
-27%
|
(12)
+65%
|
(5)
+57%
|
(8)
-60%
|
|
| Free Cash Flow | ||||||||||||||||||||||
| Free Cash Flow |
78
N/A
|
14
-82%
|
(44)
N/A
|
(71)
-63%
|
(53)
+26%
|
(47)
+11%
|
(43)
+8%
|
(246)
-469%
|
(203)
+18%
|
(140)
+31%
|
(140)
-1%
|
61
N/A
|
32
-48%
|
(18)
N/A
|
(55)
-205%
|
(83)
-51%
|
(44)
+48%
|
33
N/A
|
(84)
N/A
|
(120)
-43%
|
(176)
-46%
|
|